Airway goblet-cell mucus secretion
A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mu...
Gespeichert in:
Veröffentlicht in: | Trends in Pharmacological Sciences 2001, Vol.22 (1), p.39-45 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 45 |
---|---|
container_issue | 1 |
container_start_page | 39 |
container_title | Trends in Pharmacological Sciences |
container_volume | 22 |
creator | Jackson, Alan D |
description | A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease. |
doi_str_mv | 10.1016/S0165-6147(00)01600-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70630079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016561470001600X</els_id><sourcerecordid>70630079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_grJ4ED1EJ5vNpj1JKX5BwYMKvYU0mZXIftRkV-m_N9sWPXqZYZhn5p15CTllcM2A5TcvMQias0xeAlzFAoAu9siQjSWnXHKxT4a_yIAchfABAJyn7JAMGIudXLIhOZ86_63XyXuzLLGlBssyqTrThSSg8di6pj4mB4UuA57s8oi83d-9zh7p_PnhaTadU8Nz1lJhRcZkOtZCYzExEiWCSMdcFjZLl1yCtVbbwugstaa_Eq3mEtMCJGZsAnxELrZ7V7757DC0qnKhP0jX2HRBScg5gJxEUGxB45sQPBZq5V2l_VoxUL05amOO6j9XAGpjjlrEubOdQLes0P5N7dyIwO0WwPjml0OvgnFYG7TOo2mVbdw_Ej-eLHL7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70630079</pqid></control><display><type>article</type><title>Airway goblet-cell mucus secretion</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Jackson, Alan D</creator><creatorcontrib>Jackson, Alan D</creatorcontrib><description>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</description><identifier>ISSN: 0165-6147</identifier><identifier>EISSN: 1873-3735</identifier><identifier>DOI: 10.1016/S0165-6147(00)01600-X</identifier><identifier>PMID: 11165671</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Asthma ; Chronic bronchitis ; Goblet Cells - drug effects ; Goblet Cells - secretion ; Humans ; Metaplasia ; Mucus ; Mucus - secretion ; Preclinical models ; Secretion ; Secretory Rate - drug effects</subject><ispartof>Trends in Pharmacological Sciences, 2001, Vol.22 (1), p.39-45</ispartof><rights>2001 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</citedby><cites>FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0165-6147(00)01600-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,780,784,792,3550,4054,27922,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11165671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jackson, Alan D</creatorcontrib><title>Airway goblet-cell mucus secretion</title><title>Trends in Pharmacological Sciences</title><addtitle>Trends Pharmacol Sci</addtitle><description>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</description><subject>Animals</subject><subject>Asthma</subject><subject>Chronic bronchitis</subject><subject>Goblet Cells - drug effects</subject><subject>Goblet Cells - secretion</subject><subject>Humans</subject><subject>Metaplasia</subject><subject>Mucus</subject><subject>Mucus - secretion</subject><subject>Preclinical models</subject><subject>Secretion</subject><subject>Secretory Rate - drug effects</subject><issn>0165-6147</issn><issn>1873-3735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_grJ4ED1EJ5vNpj1JKX5BwYMKvYU0mZXIftRkV-m_N9sWPXqZYZhn5p15CTllcM2A5TcvMQias0xeAlzFAoAu9siQjSWnXHKxT4a_yIAchfABAJyn7JAMGIudXLIhOZ86_63XyXuzLLGlBssyqTrThSSg8di6pj4mB4UuA57s8oi83d-9zh7p_PnhaTadU8Nz1lJhRcZkOtZCYzExEiWCSMdcFjZLl1yCtVbbwugstaa_Eq3mEtMCJGZsAnxELrZ7V7757DC0qnKhP0jX2HRBScg5gJxEUGxB45sQPBZq5V2l_VoxUL05amOO6j9XAGpjjlrEubOdQLes0P5N7dyIwO0WwPjml0OvgnFYG7TOo2mVbdw_Ej-eLHL7</recordid><startdate>2001</startdate><enddate>2001</enddate><creator>Jackson, Alan D</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2001</creationdate><title>Airway goblet-cell mucus secretion</title><author>Jackson, Alan D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-5d541728a5aef9c7e7e052837fd42b370dddadfca42dc1873eda37e2f07e41903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Asthma</topic><topic>Chronic bronchitis</topic><topic>Goblet Cells - drug effects</topic><topic>Goblet Cells - secretion</topic><topic>Humans</topic><topic>Metaplasia</topic><topic>Mucus</topic><topic>Mucus - secretion</topic><topic>Preclinical models</topic><topic>Secretion</topic><topic>Secretory Rate - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jackson, Alan D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jackson, Alan D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway goblet-cell mucus secretion</atitle><jtitle>Trends in Pharmacological Sciences</jtitle><addtitle>Trends Pharmacol Sci</addtitle><date>2001</date><risdate>2001</risdate><volume>22</volume><issue>1</issue><spage>39</spage><epage>45</epage><pages>39-45</pages><issn>0165-6147</issn><eissn>1873-3735</eissn><abstract>A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>11165671</pmid><doi>10.1016/S0165-6147(00)01600-X</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-6147 |
ispartof | Trends in Pharmacological Sciences, 2001, Vol.22 (1), p.39-45 |
issn | 0165-6147 1873-3735 |
language | eng |
recordid | cdi_proquest_miscellaneous_70630079 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Animals Asthma Chronic bronchitis Goblet Cells - drug effects Goblet Cells - secretion Humans Metaplasia Mucus Mucus - secretion Preclinical models Secretion Secretory Rate - drug effects |
title | Airway goblet-cell mucus secretion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A18%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20goblet-cell%20mucus%20secretion&rft.jtitle=Trends%20in%20Pharmacological%20Sciences&rft.au=Jackson,%20Alan%20D&rft.date=2001&rft.volume=22&rft.issue=1&rft.spage=39&rft.epage=45&rft.pages=39-45&rft.issn=0165-6147&rft.eissn=1873-3735&rft_id=info:doi/10.1016/S0165-6147(00)01600-X&rft_dat=%3Cproquest_cross%3E70630079%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70630079&rft_id=info:pmid/11165671&rft_els_id=S016561470001600X&rfr_iscdi=true |